China Healthcare Weekly (Sep10)-2021H1 Results Summary,Hospital Compensation Reform,Injection Export
The article analyzed the summary and enlightenment of 2021H1 reports of healthcare companies, reform of public hospital compensation system, export...
252 Views
Pre-IPO Yonghe Medical Group - Here Are the Concerns
The article analyzed Yonghe Medical Group in terms of the concerns and challenges that deserve investors’ attention,including the business...
390 Views
HSCI Index Rebalance & Stock Connect: Expected Changes in September
Currently we see 28 potential inclusions & 22 deletions from the HSCI at the Sep rebalance. Most of the inclusions will join Stock Connect while...
672 Views
Industry Report - Insights on Hair Loss Prevention and Hair Growth Industry
This article analyzed China hair loss prevention and hair growth industry in terms of the market potential, the hair loss drugs, the hair...
349 Views
Kintor Pharma (开拓药业) Placement - Still Riding the COVID Momentum
Kintor Pharmaceutical (9939 HK) is looking to raise up to a total of US$183m in its concurrent top-up and secondary placement.
348 Views